Provided by Tiger Trade Technology Pte. Ltd.

3SBIO

14.990
-0.710-4.52%
Volume:34.51M
Turnover:528.98M
Market Cap:37.77B
PE:3.73
High:16.260
Open:15.900
Low:14.930
Close:15.700
52wk High:34.905
52wk Low:14.594
Shares:2.52B
HK Float Shares:2.52B
Volume Ratio:2.68
T/O Rate:1.37%
Dividend:0.25
Dividend Rate:1.68%
EPS(LYR):4.016
ROE:35.88%
ROA:22.68%
PB:1.17
PE(LYR):3.73
PS:1.81

Loading ...

三生制药2025年收入近177亿元,核心产品与全球合作驱动业绩大幅增长

Bulletin Express
·
Apr 29

3SBIO 2025 ESG Report: A-Level Rating, 48.49% Cut in Carbon Intensity and Full Anti-Corruption Coverage

Bulletin Express
·
Apr 29

3SBio Shifts to Full Electronic Distribution of Corporate Communications, Urges Non-Registered Shareholders to Submit Email Details

Bulletin Express
·
Apr 29

3SBio Issues Reminder to Shareholders on Shift to Electronic Corporate Communications

Bulletin Express
·
Apr 29

3SBio publishes 2025 annual report

Reuters
·
Apr 29

3SBio shareholders approved conditional Mandi share distribution at extraordinary general meeting

Reuters
·
Apr 23

Stock Track | 3SBIO Plummets 13.14% Intraday Amid Broader Biotech Selloff as Geopolitical Tensions and Oil Prices Dampen Rate Cut Hopes

Stock Track
·
Apr 23

Biopharma Stocks Slide Across Board as Oil Prices Squeeze Rate Cut Prospects

Stock News
·
Apr 23

CMB International Reports Moderate Recovery in Healthcare Sector Risk Appetite, Recommends Six Stocks Including Hansoh Pharma

Stock News
·
Apr 20

Stock Track | 3SBIO Soars 5.30% Intraday on Clinical Trial Approval and Institutional Endorsement

Stock Track
·
Apr 17

3SBIO Shares Surge Over 9% Afternoon on Domestic Clinical Approval for SSGJ-707 in Lung and Kidney Cancers

Stock News
·
Apr 15

Stock Track | 3SBIO Soars 5.12% Intraday on Dual IND Approval for SSS67 and Pfizer Partnership

Stock Track
·
Apr 15

Morgan Stanley Cuts 3SBIO (01530) Target Price to HK$34, Keeps "Overweight" Rating

Stock News
·
Apr 14

Stock Track | 3SBio Soars 5.05% Intraday on Strong 2025 Earnings and Undervaluation Appeal

Stock Track
·
Apr 13

Assessing 3SBio (SEHK:1530) Valuation After Strong 2025 Earnings And Affirmed Dividend

Simply Wall St.
·
Apr 13